During the past decade, Austin Hospital Olivia Newton John Cancer Centre conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Austin Hospital Olivia Newton John Cancer Centre" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Australasian Gastro-Intestinal Trials Group" with 2 trials sponsored, "BeiGene" with 1 trials sponsored, "Neoleukin Therapeutics, Inc." with 1 trials sponsored and "Regeneron Pharmaceuticals" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Austin Hospital Olivia Newton John Cancer Centre" #1 collaborator was "Academic and Community Cancer Research United" with 1 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Austin Hospital Olivia Newton John Cancer Centre" are "Advanced Solid Tumor" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Colorectal Cancer Metastatic" (1 trials), "Cutaneous Squamous Cell Carcinoma" (1 trials) and "Gastro-Oesophageal Cancer" (1 trials). Many other conditions were trialed in "Austin Hospital Olivia Newton John Cancer Centre" in a lesser frequency.

Most popular intervention types in "Austin Hospital Olivia Newton John Cancer Centre" are "Drug" (9 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (4 trials), "Docetaxel" (2 trials), "Paclitaxel" (2 trials), "Placebo" (2 trials) and "BBI608" (1 trials). Other intervention names were less common.

The vast majority of trials in "Austin Hospital Olivia Newton John Cancer Centre" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Austin Hospital Olivia Newton John Cancer Centre". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Austin Hospital Olivia Newton John Cancer Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Austin Hospital Olivia Newton John Cancer Centre, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".